355 related articles for article (PubMed ID: 16880311)
1. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
[TBL] [Abstract][Full Text] [Related]
2. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
3. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
[TBL] [Abstract][Full Text] [Related]
4. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
5. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
6. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
7. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of women with recurrent molar pregnancies.
Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
[TBL] [Abstract][Full Text] [Related]
9. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
[TBL] [Abstract][Full Text] [Related]
11. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
12. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
13. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
Niemann I; Petersen LK; Hansen ES; Sunde L
Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403
[TBL] [Abstract][Full Text] [Related]
14. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
[TBL] [Abstract][Full Text] [Related]
15. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.
Hancock BW; Nazir K; Everard JE
J Reprod Med; 2006 Oct; 51(10):764-6. PubMed ID: 17086803
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.
Feltmate CM; Batorfi J; Fulop V; Goldstein DP; Doszpod J; Berkowitz RS
Obstet Gynecol; 2003 Apr; 101(4):732-6. PubMed ID: 12681878
[TBL] [Abstract][Full Text] [Related]
17. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
18. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
Berkowitz R; Ozturk M; Goldstein D; Bernstein M; Hill L; Wands JR
Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
[TBL] [Abstract][Full Text] [Related]
19. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
[TBL] [Abstract][Full Text] [Related]
20. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2006 Mar; 107(3):743. PubMed ID: 16507954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
